Obsidian Therapeutics Inc. (OBX)
$17.15
At close+0.11 (+0.65%)
Something off on this page? Send us feedback.
Obsidian Therapeutics Inc.OBXHealth Care
Not reported.
Company facts
CEOMadan Jagasia
ListedAug 4, 2026
ExchangeNASDAQ
HeadquartersCambridge, MA
CountryUnited States
Employees3
CIK0002130606
ISINUS67448A1060
Market cap$17.7M
EPS (ttm)—
P/E (ttm)—
ROE—
P/B—
P/S—
Dividend yieldDiv yield—
Beta—
Unavailable right now.
EPSReportedEstimate
——————Aug '26Aug '26
Reported——————−$2.05−$2.05
Estimate——————−$2.05−$1.63
Surprise——————0.0%−25.8%
RevenueReportedEstimate
——————Aug '26Aug '26
Reported————————
Estimate————————
Surprise————————
Estimate−$1.63
Reported−$2.05−25.8%
Estimate—
Reported—
Not reported.
No dividends on record.
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Deep Track Capital, LPStrategic | —5.37% of class, as filed | — | 13Gfiled Aug 11, 2026 ↗ |
Novo Holdings A/SStrategic | —5.10% of class, as filed | — | 13Gfiled Aug 10, 2026 ↗ |
RA Capital Management, L.P.Institution | —9.70% of class, as filed | — | 13Gfiled Aug 10, 2026 ↗ |
13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
No open-market trades in the last 12 months.
Not reported.